X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (58) 58
cardiac & cardiovascular systems (48) 48
humans (41) 41
heart failure (38) 38
male (25) 25
mortality (24) 24
aged (23) 23
female (23) 23
hospitalization (21) 21
outcomes (20) 20
heart failure - therapy (17) 17
prognosis (17) 17
cardiovascular (16) 16
middle aged (16) 16
heart failure - physiopathology (15) 15
registries (14) 14
heart failure - diagnosis (12) 12
heart failure - drug therapy (12) 12
management (12) 12
prospective studies (11) 11
risk factors (11) 11
treatment outcome (11) 11
abridged index medicus (10) 10
acute disease (10) 10
acute heart failure (10) 10
article (10) 10
association (10) 10
cardiology (10) 10
european-society (10) 10
guidelines (10) 10
heart failure - epidemiology (10) 10
heart failure - mortality (10) 10
hospitalization - statistics & numerical data (10) 10
heart attacks (9) 9
diagnosis (8) 8
echocardiography (8) 8
epidemiology (8) 8
task-force (8) 8
cardiotonic agents - therapeutic use (7) 7
clinical trials (7) 7
europe - epidemiology (7) 7
follow-up studies (7) 7
kardiologi (7) 7
klinisk medicin (7) 7
medicin och hälsovetenskap (7) 7
stroke volume (7) 7
cardiac and cardiovascular systems (6) 6
clinical medicine (6) 6
drug therapy (6) 6
heart failure - blood (6) 6
medical and health sciences (6) 6
natriuretic peptide (6) 6
pharmacology & pharmacy (6) 6
preserved ejection fraction (6) 6
registry (6) 6
surgery (6) 6
time factors (6) 6
tolvaptan (6) 6
acute myocardial-infarction (5) 5
antidiuretic hormone receptor antagonists - therapeutic use (5) 5
benzazepines - therapeutic use (5) 5
biomarkers - blood (5) 5
cardiac patients (5) 5
clinical characteristics (5) 5
double-blind method (5) 5
electrocardiography (5) 5
europe (5) 5
inpatients (5) 5
natriuretic peptides (5) 5
patients (5) 5
reduced ejection fraction (5) 5
risk stratification (5) 5
acute disease - therapy (4) 4
analysis (4) 4
comorbidity (4) 4
disease management (4) 4
diuretics - therapeutic use (4) 4
double-blind (4) 4
ejection fraction (4) 4
eurobservational research-program (4) 4
heart failure - complications (4) 4
heart failure - etiology (4) 4
hospital mortality (4) 4
hospital mortality - trends (4) 4
hypertension (4) 4
medical colleges (4) 4
medicine (4) 4
morbidity (4) 4
practice guidelines as topic (4) 4
renal-function (4) 4
risk (4) 4
romania - epidemiology (4) 4
societies, medical (4) 4
stroke - epidemiology (4) 4
stroke volume - physiology (4) 4
survival rate - trends (4) 4
30-day readmission (3) 3
acute (3) 3
acute coronary syndromes (3) 3
acute disease - mortality (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Heart Failure, ISSN 1388-9842, 08/2019, Volume 21, Issue 8, pp. 953 - 954
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 10/2019, Volume 21, Issue 10, pp. 1228 - 1230
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 09/2018, Volume 20, Issue 9, pp. 1323 - 1325
Journal Article
European journal of heart failure, ISSN 1388-9842, 07/2019
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 03/2018, Volume 20, Issue 3, pp. 533 - 535
Journal Article
Heart Failure Reviews, ISSN 1382-4147, 11/2019, Volume 24, Issue 6, pp. 997 - 1004
Cardiogenic shock (CS) is increasingly recognized in patients with malignancies, while cancer is independently associated with worse prognosis in CS. A number... 
Chemotherapy | Medicine & Public Health | Cardiology | Radiotherapy | Cardiogenic shock | Cancer | Myocarditis | Cardiomyopathy | Medical prognosis | Surgery | Conditioned stimulus | Radiation therapy | Heart diseases | Embolism | Tamponade
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 10/2019, Volume 293, pp. 176 - 178
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 115, Issue 6, pp. 790 - 796
Both hyperkalemia and hypokalemia may be related to heart failure (HF) therapy and are associated with adverse outcomes. Abnormalities in serum potassium... 
Cardiovascular | MORTALITY | MILD | PLACEBO | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTAGONIST | RATIONALE | HYPERKALEMIA | RENAL-FUNCTION | DOUBLE-BLIND | TOLVAPTAN | CHRONIC KIDNEY-DISEASE | Hyperkalemia - blood | Follow-Up Studies | Hypokalemia - blood | Humans | Middle Aged | Heart Failure - physiopathology | Male | Heart Failure - blood | Inpatients | Life Expectancy | Female | Heart Failure - diagnosis | Hyperkalemia - etiology | Hypokalemia - etiology | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Clinical Trials as Topic | Biomarkers - blood | Antidiuretic Hormone Receptor Antagonists - therapeutic use | Heart Failure - drug therapy | Stroke Volume | Benzazepines - therapeutic use | Creatinine - blood | Potassium - blood | Aged | Research Design | Heart failure | Enzymes | Care and treatment | Pituitary hormones | Corticosteroids | Mortality | Adrenergic beta blockers | Homeopathy | Materia medica and therapeutics | Analysis | Cardiac patients | Therapeutics | Angiotensin | Diuretics | Hospitalization | Heart attacks | Life Sciences | Hyperkalemia | Benzazepines | Hypokalemia | Heart Failure | Cardiology and cardiovascular system | Creatinine | Human health and pathology | Biomarkers | Antidiuretic Hormone Receptor Antagonists | Potassium | Kardiologi | Cardiac & Cardiovascular Systems | Cardiac and Cardiovascular Systems
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2014, Volume 63, Issue 12, pp. 1123 - 1133
Heart failure is a global pandemic affecting an estimated 26 million people worldwide and resulting in more than 1 million hospitalizations annually in both... 
acute | heart failure | registry | hospitalization | inpatient | VENTRICULAR EJECTION FRACTION | CARDIAC & CARDIOVASCULAR SYSTEMS | QUALITY-OF-CARE | OPTIMIZE-HF REGISTRY | ORGANIZED PROGRAM | EUROBSERVATIONAL RESEARCH-PROGRAM | STROKE STATISTICS-2012 UPDATE | INITIATE LIFESAVING TREATMENT | ONE-YEAR MORTALITY | PHYSICIAN FOLLOW-UP | PRESERVED SYSTOLIC FUNCTION | Age Distribution | Vasodilator Agents - therapeutic use | Anemia - epidemiology | United States | Humans | Catheterization, Swan-Ganz - utilization | Male | Dyspnea - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Electrocardiography | Female | Registries | Coronary Angiography - utilization | Heart Failure - diagnosis | Heart Failure - epidemiology | Heart Failure - etiology | Drug Utilization - statistics & numerical data | Length of Stay - statistics & numerical data | Adrenergic beta-Antagonists - therapeutic use | Hyponatremia - epidemiology | Cardiac Resynchronization Therapy - utilization | Echocardiography | Glomerular Filtration Rate | Hospital Mortality | Comorbidity | Europe | Defibrillators, Implantable - utilization | Hospitalization | Evidence-Based Medicine | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Quality Improvement | Asia | Natriuretic Peptides - analysis | Sex Distribution | Diuretics - therapeutic use | Aged | Angiotensin Receptor Antagonists - therapeutic use | Heart failure | Medical colleges | Medical research | Mortality | Therapeutics | Economic aspects | Medicine, Experimental | Natriuretic peptides | Homeopathy | Materia medica and therapeutics
Journal Article
by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ... and COMPASS Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Cardiovascular Diseases | Factor Xa Inhibitors | Klinisk medicin | Hemorrhage | epidemiology | Rivaroxaban | administration & dosage | Combination | Amputation | Drug | drug therapy | chemically induced | complications | prevention & control | Peripheral Arterial Disease | etiology | Clinical Medicine | Myocardial Infarction | statistics & numerical data | blood supply | Carotid Artery Diseases | Platelet Aggregation Inhibitors | adverse effects | mortality | Lower Extremity | Dose-Response Relationship | therapeutic use | surgery
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 114, Issue 11, pp. 1713 - 1721
Journal Article
Journal Article
Journal Article